Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1

Completed · Phase 1/Phase 2

Conditions studied: Opioid-Related Disorders

In brief

The purpose of this study is to compare subject response to liquid vs. tablet formulations, to assess bioequivalency of liquid vs. tablet, to compare subject preference, and to evaluate if dose response curve for tablet is equal to liquid form."

Key facts

Study ID

NCT00000320

Run by

National Institute on Drug Abuse (NIDA)

People needed

120

Starts

1997-10-01

Expected to finish

1999-08-01

Last updated by the study team

2017-01-12

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• M/F ages 18-65. Meet DMS-IV criteria for opiate dependence. Agree to conditions of the study and sign informed consent.

You may not qualify if…

• Pregnant or nursing women. Acute medical condition that would interfere with study participation or put safety of subjects in jeopardy. Current daily use of anti-convulsants, antabuse or neuroleptics. DSM-IV diagnosis of ETOH or sedative/hypnotics dependence.

Where it is running

• Friends Research Institute — Los Angeles, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.